Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus responseEmilia Alors‐Pérez, Justo P. Castaño, Marina Sánchez‐Frías et al.|Molecular Therapy — Nucleic Acids|2023Cited by 13
Dysregulation of CELF4 splicing factor in pancreatic neuroendocrine tumors enhances aggressiveness and alters mTOR pathway and everolimus responseJusto P. Castaño, Alejandro Ibáñez‐Costa, Emilia Alors‐Pérez et al.|Research Square|2022Cited by 0
Dysregulation of CELF4 Splicing Factor in Pancreatic Neuroendocrine Tumors Enhances Aggressiveness and Alters Mtor Pathway and Everolimus ResponseEmilia Alors‐Pérez, Justo P. Castaño, Sergio Pedraza‐Arévalo et al.|SSRN Electronic Journal|2022Cited by 0